| ¿µ¹® | toxicity | ÇÑ±Û | µ¶¼º |
|---|---|---|---|
| ¼³¸í | »ýü¿¡ ÀÖ¾î ¹Ù¶÷Á÷ÇÏÁö ¾ÊÀº ¾à¹° ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¾à¹°À» °ú·®À¸·Î »ç¿ëÇϸé Áßµ¶À» ÀÏÀ¸Å°¸ç, ½ÉÇÑ °æ¿ì¿¡´Â Á×À½¿¡ À̸£´Âµ¥ ÀÌ´Â ¾à¹°ÀÇ ±Þ¼º µ¶¼ºÀÌ´Ù. ¸¸¼º µ¶¼ºÀº ¼Ò·®À» Àå±â°£ ¹Ýº¹ ¼·ÃëÇÏ¿´À» ¶§ÀÇ µ¶¼ºÀÌ´Ù. °£, ÄáÆÏ µî ¿©·¯ Àå±â¿Í Á¶Á÷¿¡ ´ëÇÑ µ¶¼º ¿Ü¿¡, ±âÇüÀ¯¹ß¼º, ¹ß¾Ï¼º µîµµ ¾à¹°µ¶¼ºÀÌ´Ù. ¾à¹°µ¶¼ºÀÇ °¾àÀº ±Þ¼º µ¶¼º°Ë»ç(LD50), ¸¸¼º µ¶¼º°Ë»ç, ±âÇüÀ¯¹ß°Ë»ç, ¹ß¾Ï°Ë»ç, ¹ø½Ä°Ë»ç ±âŸ ¿©·¯ µ¿¹°°Ë»ç¿¡ ÀÇÇØ ÆÇÁ¤µÈ´Ù. |
||
| ¿µ¹® | acetabular index | ÇÑ±Û | Àý±¸Áö¼ö, °ü°ñ±¸Áö¼ö |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ Àý±¸´Â °ñ¹ÝÀÇ 3°³ÀÇ »À. Áï ¾ûµ¢»À, µÎµ¢»À, ±ÃµÕ»À·Î ¸¸µé¾îÁö´Â µ¥ ¼Ò¾Æ¿¡¼± ¾ÆÁ÷ ¿ÏÀüÇÑ »ÀµÇ±â°¡ ÀϾÁö ¾Ê¾Æ¼ ÀÌ ºÎºÐÀÌ »ï¹æ¿¬°ñÀý±¸·Î ¿¬°áµÇ¾î ÀÖ´Ù. ÀÌ »ï¹æ¿¬°ñÀ» ¿¬°áÇÑ ¼±°ú Àý±¸°¡Âʳ¡°ú »ï¹æ¿¬°ñÀÇ ¾ÈÂÊÀ» ¿¬°áÇÑ ¼±°úÀÇ °¢À» ¸»ÇÑ´Ù. ÀÌ °¢ÀÌ 40µµ ÀÌ»óÀ̸é Àý±¸ÀÇ ÀÌ»ó ¹ßÀ°À» ÀǹÌÇÑ´Ù. |
||
| CI | cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar... |
|---|---|
| MI | first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect... |
| PI | first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;... |
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
| ISI | infarct size index; initial slope index; injury severity index; Institute for Scientific Information... |
| CTC | Common Toxicity Criteria |
|---|---|
| DLT | Dose limiting toxicity |
| RRT | Regimen related toxicity |
| TCLP | Toxicity Characteristic Leaching Procedure |
| TIE | Toxicity Identification Evaluation |
| acute toxicity | <pharmacology> Illness resulting from a single dose or exposure to a toxic substance. Compare: chronic toxicity. (06 May 1997) |
|---|---|
| chronic toxicity | <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance. Compare: acute toxicity. (09 Oct 1997) |
| digitalis toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| digoxin toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| drug toxicity | The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug. (27 Sep 1997) |
| oxygen toxicity | A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation. Synonym: oxygen poisoning. (05 Mar 2000) |
| toxicity | The quality of being poisonous, especially the degree of virulence of a toxic microbe or of a poison. (18 Nov 1997) |
| toxicity test | <investigation> Controlled laboratory test to determine the toxicity of a chemical to an organism in terms of specific chemical concentrations. An acute toxicity test establishes the concentration required to kill a predetermined proportion of test organisms within a relatively short period of time, typically 4 days or less. A chronic toxicity test reveals the effects of a sublethal concentration applied throughout all or part of the life cycle. (12 Jan 1998) |
| toxicity tests | Tests that determine the toxicity of a substance. These include tests of clinical drugs, foods, environmental pollutants, etc. (12 Dec 1998) |
| ep toxicity | A test defined by the federal Environmental Protection Agency to check a substance for the presence of arsenic, barium, cadmium, chromium, lead, mercury, selenium, or silver. 40 CFR 261.24 defines the concentrations constituting hazardous waste and the test procedure. (05 Dec 1998) |
| absorbancy index | Absorbance (of light) per unit path length (usually the centimeter) and per unit of mass concentration. Compare: molar absorption coefficient. Synonym: absorbancy index, absorptivity, extinction coefficient, specific extinction. (05 Mar 2000) |
| alveolar index | Relation between the basialveolar (basion to alveolar point) and basinasal (basion to nasion) lengths: (basialveolar length × 100)/basinasal length; the result indicates the degree of projection of the maxilla or upper jaw. Synonym: alveolar index. (05 Mar 2000) |
| anaesthetic index | Ratio of the number of units of anaesthetic required for anaesthesia to the number of units of anaesthetic required to produce respiratory or cardiovascular failure. (05 Mar 2000) |
| antitryptic index | An obsolete term for the relative retardation in loss of viscosity of a solution of casein incubated with trypsin, to which a drop of abnormal blood serum (as from a cancerous patient) has been added, compared with that in a similar solution to which normal serum has been added; if the former drips through the tube of the viscosimeter in 100 seconds, and the latter in 104 seconds, the antitryptic index is 4. (05 Mar 2000) |
| Arneth index | An expression based on adding the percentages of polymorphonuclear neutrophils with 1 or 2 lobes in their nuclei, plus one-half the percentage with 3 lobes; the normal value is 60%. See: Arneth formula, Arneth count. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|